The majority of these procedures experienced a notable reduction in the cancer subcategories exhibiting elevated HPDL levels, except for BRCA, CHOL, DLBC, ESCA, KIRC, LGG, PCPG, PRAD, and UVM. This evidence concerns the gene HPDL and cancer.